Abstract Introduction Lack of information may result in health professionals’ negative attitudes toward individuals with mental illness. Objective We sought to determine the association between the perception of aggressiveness–dangerousness and illness recognition, suggested treatment, and attitudes regarding schizophrenia and bipolar disorder in a group of medical students. Method This field study used a non-experimental, cross-sectional comparative design in a purposive sample of medical students. Mental illness recognition, beliefs about adequate treatment, perception of patient’s aggressiveness-dangerousness, and attitudes toward severe mentally ill persons were assessed with previously validated instruments. Results Of the 104 participants, 54.8% identified a mental health condition in the schizophrenia vignette compared with only 3.8% in the case of bipolar disorder. Most students believed that both diagnoses could lead to aggressive behaviors. Dangerousness was more frequently perceived in the schizophrenia vignette. Discussion and conclusion It is necessary to sensitize and educate medical students so they have accurate information about symptoms and available treatments for individuals with mental illnesses.

Resumen Introducción La falta de información puede dar como resultado actitudes negativas de los profesionales de la salud hacia los individuos con trastornos mentales. Objetivo Determinar la asociación entre la percepción de agresión-peligrosidad y el reconocimiento de la enfermedad, tratamiento sugerido y actitudes sobre la esquizofrenia y el trastorno bipolar en un grupo de estudiantes de pregrado de medicina. Método El presente es un estudio no experimental, transversal comparativo en una muestra propositiva de estudiantes de medicina. El reconocimiento de la enfermedad, creencias acerca del tratamiento más adecuado, percepción de la agresión-peligrosidad del paciente y las actitudes hacia los trastornos mentales graves fueron evaluados con instrumentos previamente validados. Resultados El 54.8% de un total de 104 participantes identificaron un estado de salud mental en la viñeta de esquizofrenia en contraste con tan sólo el 3.8% para el caso de trastorno bipolar. La mayoría de los estudiantes consideraron que ambos diagnósticos se relacionaban con conductas agresivas. La peligrosidad fue percibida más frecuentemente en la viñeta del caso con esquizofrenia. Discusión y conclusión Es necesario sensibilizar y educar a los estudiantes de medicina para que tengan información clara y precisa sobre los síntomas y tratamientos disponibles para los individuos con trastornos mentales.

Low- and middle-income countries (LMIC) lack the research infrastructure and capacity to conduct rigorous substance abuse and mental health effectiveness clinical trials to guide clinical practice. A partnership between the Florida Node Alliance of the United States National Drug Abuse Treatment Clinical Trials Network and the National Institute of Psychiatry in Mexico was established in 2011 to improve substance abuse practice in Mexico. The purpose of this partnership was to develop a Mexican national clinical trials network of substance abuse researchers and providers capable of implementing effectiveness randomized clinical trials in community-based settings. A technology transfer model was implemented and ran from 2011-2013. The Florida Node Alliance shared the "know how" for the development of the research infrastructure to implement randomized clinical trials in community programs through core and specific training modules, role-specific coaching, pairings, modeling, monitoring, and feedback. The technology transfer process was bi-directional in nature in that it was informed by feedback on feasibility and cultural appropriateness for the context in which practices were implemented. The Institute, in turn, led the effort to create the national network of researchers and practitioners in Mexico and the implementation of the first trial. A collaborative model of technology transfer was useful in creating a Mexican researcher-provider network that is capable of changing national practice in substance abuse research and treatment. Key considerations for transnational technology transfer are presented.

Los países de ingresos bajos o medios (PIBM) carecen de una infraestructura de investigación y de la capacidad para llevar a cabo investigaciones clínicas rigurosas sobre la eficacia del tratamiento de la drogadicción y los problemas de salud mental que orienten la práctica clínica. Se estableció una asociación entre la Florida Node Alliance de la National Drug Abuse Treatment Clinical Trials Network de los Estados Unidos y el Instituto Nacional de Psiquiatría de México con objeto de mejorar la práctica en materia de tratamiento de la drogadicción en México. La finalidad de esta asociación fue la de crear una red nacional mexicana de investigaciones clínicas constituida por investigadores y proveedores de tratamiento de la drogadicción capaces de ejecutar ensayos clínicos aleatorizados de eficacia en entornos comunitarios. Se implantó un modelo de transferencia de tecnologías. La Florida Node Alliance compartió el el conocimiento y la experiencia para la creación de la infraestructura de investigación con objeto de ejecutar investigaciones clínicas aleatorizadas en programas comunitarios, por medio de módulos de capacitación común y específica, entrenamiento en funciones específicas, emparejamientos, modelado, vigilancia y retroalimentación. El proceso de transferencia de tecnología fue de tipo bidireccional en cuanto se basó en la retroalimentación sobre la viabilidad y la adecuación cultural para el contexto en el que se llevaron a cabo las prácticas. El Instituto, a su vez, lideró la iniciativa para crear la red nacional de investigadores y profesionales de México y llevar a cabo el primer ensayo. Un modelo colaborativo de transferencia de tecnología resultó útil para la creación de una red mexicana de investigadores y proveedores de tratamiento capaz de cambiar las prácticas nacionales de investigación y tratamiento en materia de drogadicción. Se exponen las consideraciones clave para la transferencia transnacional de tecnología.

Duplex stainless steels are susceptible to the formation of sigma phase at high temperature which could potentially be responsible for catastrophic service failure of components. Thermal treatments were applied to duplex stainless steels in order to promote the precipitation of different fractions of sigma phase into a ferrite-austenite microstructure. Quantitative image analysis was employed to characterize the microstructure and Charpy impact tests were used in order to evaluate the mechanical degradation caused by sigma phase presence. The fracture morphology of the Charpy test specimens were thoroughly observed in SEM, looking for a correlation between the microstructure and the fracture types in UNS S32205 duplex stainless steel. The main conclusion is the strong embrittlement effect of sigma phase since it is possible to observe a transition from transgranular fracture to intergranular fracture as increases the percentage of sigma phase. Thus, the mixed modes of fracture are predominant in the present study with high dependence on sigma phase percentages obtained by different thermal treatments.

According to epidemiologic reports, the harmful use of alcohol and illicit drugs has increased among the Mexican population. This use is associated to several risks and issues that affect public health and the public well-being of the country. In this article it is acknowledged the need for development of treatment models and interventions whose therapeutic value is demonstrated by scientific evidence, that respond to the attention needs of the population affected by substance use in our country and that can be generalized in community clinical practice. In clinical research, randomized controlled clinical trials (RCT's) are the "gold standard" to demonstrate the effect of a therapeutic intervention. A randomized controlled clinical trial is a prospective study in which the effect, value and safety of one or various experimental interventions are tested against a "control" intervention in human subjects. Acknowledging that in Mexico there is a lack of research on addiction treatment that is compliant with all the requirements to be considered as an RCT, this article presents some methodological and ethical considerations that are neccesary for their design and conduction. These considerations include from the establishment of a relevant research question and objectives, adequate study design, development of strategies for data management, statistical analysis, monitoring of interventions, safety monitoring and research quality assurance and protection of human subjects.

Según reportes epidemiológicos, el consumo nocivo de alcohol y drogas ilegales dentro de la población mexicana ha ido en aumento, lo que se asocia a varios riesgos o problemáticas que afectan la salud y bienestar públicos del país. Se reconoce la necesidad de desarrollar modelos de tratamiento e intervenciones cuyo valor terapéutico esté respaldado por la evidencia científica, que respondan a las necesidades de atención de la población afectada por el consumo de sustancias en nuestro país y que puedan generalizarse en la práctica clínica comunitaria. Dentro de la investigación clínica, el "estándar de oro" para demostrar el efecto de una intervención terapéutica son los ensayos clínicos controlados aleatorizados (ECCA). Un ECCA es un estudio prospectivo en el cual se prueba el efecto, valor y seguridad de una o varias intervenciones experimentales contra una intervención "control" en sujetos humanos. Reconociendo que en México hay una falta de investigaciones sobre tratamientos para las adicciones que cumplan con todos los requisitos para ser considerados ECCA, en este artículo se presentan distintas consideraciones metodológicas y éticas que deben tomarse en cuenta para su diseño y conducción en la materia; abarcando aspectos que parten desde el establecimiento de una pregunta y objetivos relevantes hasta el diseño adecuado del estudio y el desarrollo de estrategias para la administración de datos, análisis estadístico, monitoreo de las intervenciones, monitoreo de seguridad y aseguramiento de la calidad de la investigación y protección de los sujetos humanos que participan.

Introduction Developing mental health literacy in students and health professionals in general implies gaining abilities in recognizing and treating mental illnesses. In bipolar disorder, this is an important issue due that it helps reducing stigma and the treatment gap found in patients with this diagnosis. Objective To determine the associations between some variables of mental health literacy (illness, recognition, attributable causes and suggested treatment) about bipolar disorder with gender and perception of aggressiveness/dangerousness in a group of medical students. Material and methods One-hundred and three medical students from a public university in Mexico City completed the Aggressiveness Public Concept Questionnaire to assess mental health literacy and aggressiveness/dangerous-ness perception. Results 59.6% of students did not recognize the presence of a mental illness. As described symptoms were not considered as a manifestation of a mental disorder, 83.7% considered non-psychiatric interventions as the most adequate alternative for the management of the behaviors exposed in the vignette. 87.7% considered that the person described in the vignette was aggressive and 33.7% perceived the subject as dangerous. Discussion Campaigns of mental health literacy for medical students must be directed to improve recognition of the essential features of bipolar disorder, therapeutic options as well as the real prevalence and methods of prevention of aggressiveness of these patients.

Introducción La alfabetización en salud sental (ASM) por parte de estudiantes y profesionales de la salud implica su capacidad para reconocer la enfermedad mental y su adecuado manejo, y constituye un elemento esencial para reducir el estigma y la brecha de tratamiento de los pacientes con trastorno bipolar (TBP). Objetivo Determinar la asociación entre algunas variables de la ASM (reconocimiento, causas atribuibles y tratamiento sugerido) para el TBP con el género y la percepción de agresividad en un grupo de estudiantes de medicina. Material y métodos Ciento tres estudiantes de pregrado de la carrera de Medicina de una Universidad pública de la Ciudad de México completaron el Cuestionario de Concepto Público de Agresividad (CPA) para valorar la ASM y la percepción de agresividad/peligrosidad. Resultados El 59.6% de los estudiantes no reconocieron la presencia de una enfermedad mental. Al no considerar los síntomas como la manifestación de una enfermedad mental, el 83.7% sugirió intervenciones no psiquiátricas/no restrictivas para el manejo adecuado de las conductas expuestas en la viñeta clínica. El 87.7% de los estudiantes consideró que la persona descrita era agresiva y el 33.7% la percibió como peligrosa. Discusión Las campañas de ASM para estudiantes de medicina deben abocarse a incrementar el conocimiento de las características esenciales del TBP, las opciones de tratamiento así como la prevalencia real y métodos de prevención de la agresividad en estos pacientes.

Background Early onset mania (MIMT), compared with adolescent onset mania (MIA), has a different clinical presentation of classic mania adult onset (MIEA). Patients with MIA have a course more like the MIEA. Externalizing disorders (ADHD, ODD, and TC) have been associated with an earlier age of onset of bipolar disorder and as a marker of poor prognosis. Our goal is to determine the frequency of symptoms related to disruptive behavior disorders in patients with bipolar disorder start very early, early and adult evaluated retrospectively. Methods The total sample (N=64) of adolescent and adult patients was obtained from the National Institute of Psychiatry (INPRF) clinics. The diagnosis was confirmed by the research team. Patients signed the informed asentment and consentment. We applied the K SADS PL Mexico, MINI and MINI KID. We used the EEPE-AA for externalizing disorders. Results There were significant differences in scores compared by EEPE AA EIED groups in the Inattention subscale for GIMT. The presence of ADHD, ODD, TC and Suicide Risk in the time of evaluation was significantly associated with an earlier onset. Discussion and conclusion Our data supports the clinical utility and importance of separating the TBP by age of onset. The detection of externalizing disorders may speak of an early onset of the disorder and may also have implications for prognosis and psychopharmacological treatment, since the TBP-onset childhood to adulthood remains similar and difficult to manage. This suggests that we must have a longitudinal view of this disorder.

Antecedentes La manía de inicio muy temprano (MIMT), comparada con la manía de inicio en la adolescencia (MIA), tiene una presentación clínica distinta a la manía clásica de inicio en la adultez (MIEA). Los pacientes con MIA tienen un curso más parecido a la MIEA. Los trastornos externalizados (TDAH, TND y TC) se han asociado con una edad de inicio más temprano del TBP y como un marcador de mal pronóstico. Nuestro objetivo es determinar la frecuencia de los síntomas relacionados con los trastornos de la conducta disruptiva en pacientes con TBP de inicio muy temprano, temprano y en el adulto evaluados de manera retrospectiva. Método La muestra total (N=64) de pacientes adolescentes y adultos se obtuvo de distintas clínicas del Instituto Nacional de Psiquiatría (INPRF). El diagnóstico fue confirmado por el equipo de investigación y se solicitó la firma del asentimiento y consentimiento informado. Se aplicaron el K SADS PL México, MINI y MINI KID. Se utilizó la EEPE-AA para los trastornos externalizados. Resultados Se encontraron diferencias significativas en las puntuaciones del EEPE AA comparadas por los grupos de EIED, en la Subescala de Inatención para el GIMT. La presencia de TDAH, TND, TC y riesgo suicida en el momento de la evaluación se relacionó significativamente con un inicio más temprano. Discusión y conclusión Nuestros datos apoyan la importancia y utilidad clínica de separar el TBP por edad de inicio y la detección de trastornos externalizados podría hablarnos de un inicio temprano del trastorno. Asimismo, tiene implicaciones en el pronóstico y tratamiento psicofarmacológico, ya que el TBP de inicio en la infancia permanece en la adultez con características similares, así como de difícil manejo. Es necesario tener una visión longitudinal de este padecimiento.

Many precise aspects of the etiology and pathophysiology of mental disorders are still unknown. Susceptibility to these disorders depends in part on variability in the genome sequence among individuals. The genotype, a given environment, a specific epigenetic profile and stochastic factors affect the phenotype, which includes body structures, physiological processes, and behavior. Since the access to the Central Nervous System is generally difficult and in most cases there are still no biological tests that necessarily contribute to diagnosis, psychiatric phenotypes are usually limited to clinical symptoms and functioning. Therefore, researchers are currently seeking alternatives to facilitate the identification of genetic risk factors. One strategy is to identify measurable biological, cognitive, and behavioral markers, intermediate phenotypes, or endophenotypes, which in the best case may be simpler than general psychiatric diagnoses, ideally with a precise biological meaning and a more direct relationship with the action of specific genes. Endophenotypes have been very useful in other fields of medicine. Currently, there are several proposed criteria and specifications for endophenotypes. Examples of possible types of endophenotypes or biomarkers, as well as treatment response phenotypes in some psychiatric disorders will be discussed in this review.

Aún se desconocen diversos aspectos de la etiología y fisiopatología de los trastornos mentales. La susceptibilidad a éstos depende en parte de la variabilidad en la secuencia genómica en las personas. El genotipo, un ambiente dado, un perfil epigenético específico y factores estocásticos afectan el fenotipo, el cual incluye estructuras corporales, procesos fisiológicos y conducta. Los fenotipos psiquiátricos generalmente se limitan al funcionamiento y a los síntomas clínicos, debido a que el acceso al Sistema Nervioso Central es complicado y en la mayoría de los casos no hay pruebas biológicas que necesariamente contribuyan al diagnóstico. Por esta razón, en la actualidad se buscan alternativas para facilitar la identificación de factores de riesgo de tipo genético. La identificación de marcadores biológicos, cognitivos o conductuales medibles, fenotipos intermedios o endofenotipos podría ser una de estas nuevas opciones. Estos marcadores podrían ser más simples que el diagnóstico psiquiátrico general, y de manera ideal tendrían un significado biológico preciso y una acción más directa en los genes. El empleo de endofenotipos ha sido útil en otras ramas de la medicina. Hasta ahora se han propuesto diversos criterios y especificaciones para los endofenotipos. En esta revisión se describirán posibles tipos de endofenotipos o biomarcadores, así como fenotipos relacionados con la respuesta farmacológica en algunos trastornos psiquiátricos.

Dementias are progressive and neurodegenerative neuropsychiatry disorders, with a high worldwide prevalence. These disorders affect memory and behavior, causing impairment in the performance of daily activities and general disability in the elders. Cognitive impairment in these patients is related to anatomical and structural alterations at cellular and sub-cellular levels in the Central Nervous System. In particular, amyloid plaques and neurofibrillar tangles have been defined as histopathological hallmarks of Alzheimer's disease. Likewise, oxidative stress and neuroinflammation are implicated in the etiology and progression of the disease. Neuronal precursors from human olfactory neuroepithelium have been recently characterized as an experimental model to identify neuropsychiatric disease biomarkers. Moreover, this model not only allows the study of neuropsychiatric physiopathology, but also the process of neurodevelopment at cellular, molecular and pharmacological levels. This review gathers the evidence to support the potential therapeutic use of melatonin for dementias, based on its antioxidant properties, its anti-inflammatory effect in the brain, and its ability to inhibit both tau hyper-phosphorylation and amyloid plaque formation. Furthermore, since melatonin stimulates neurogenesis, and promotes neuronal differentiation by inducing the early stages of neuritogenesis and dendrite formation, it has been suggested that melatonin could be useful to counteract the cognitive impairment in dementia patients.

Las demencias son enfermedades neuropsiquiátricas, progresivas, neurodegenerativas y con una alta prevalencia a nivel mundial. Ocupan uno de los primeros lugares como enfermedades que causan incapacidad en los adultos mayores. En estos pacientes el Sistema Nervioso Central presenta alteraciones anatómico-estructurales a nivel celular y subcelular que se asocian con deficiencias cognitivas. En particular, en la enfermedad de Alzheimer se han caracterizado marcadores histopatológicos como las placas amiloides y las marañas neurofibrilares. Se sabe que el estrés oxidativo y la neuroinflamación participan en la etiología y el desarrollo de la enfermedad. Recientemente se caracterizó a los precursores neuronales del neuroepitelio olfatorio humano como un modelo experimental adecuado para identificar biomarcadores de rasgo y para estudiar la fisiopatología de diversas enfermedades neuropsiquiátricas, así como el proceso del neurodesarrollo, a nivel celular, molecular y farmacológico. En este trabajo se presenta la evidencia que sustenta que la melatonina puede ser útil en el tratamiento de las demencias, por su capacidad antioxidante, por su efecto anti-inflamatorio, así como por el efecto inhibidor de la hiperfosforilación de la proteina tau y de la formación de placas amiloides. Además, al estimular la formación de nuevas neuronas, la neuritogénesis en sus etapas tempranas y la formación de dendritas, la melatonina podría contribuir a contrarrestar la pérdida de las funciones cognitivas que se observa en estos padecimientos.

Introduction Perception of environment and reality stems mainly from factors determined by social and cultural influences. Several socialization processes promote the development of relations that endorse or reject certain values or identities. Unfortunately, many of these relations arise from prejudiced values that generate negative attitudes such as stigmatization or discrimination toward some persons. According to psychosocial models, generation of stigma is a consequence of three aspects: lack of knowledge about the person's condition (ignorance); development of negative attitudes (prejudice) and a tendency to exclude or reject some individuals (discrimination). Particularly, in mental health problems, general public knowledge of severe mental illnesses such as schizophrenia frequently develops in accordance to myths and misconceptions. For example, schizophrenics are commonly viewed as mad and incompetent individuals that produce fear and rejection. These erroneous conceptions originate from considering that they are incapable of controlling their acts, thus giving rise to aggressive, violent or dangerous conducts. Stigmatization impacts patients increasing depressive symptoms, anxiety and social withdrawal. Stigma also has a negative impact on diagnosis and treatment; timely diagnostic interventions and specialized treatments are frequently delayed in stigmatized individuals. Although it is reasonable to anticipate that stigmatization attitudes are more common among persons with low cultural levels, many studies have demonstrated that unfortunately this problem is also present in many health professionals, including those who work with the mentally ill. For these reasons different attempts have developed to reduce stigma by means of mental health literacy interventions oriented to modify and eliminate misconceptions about mental patients and their illness. In this sense, mental health literacy is defined as any educational intervention aimed to increase recognition, management and prevention of mental illness. Many studies have demonstrated that this type of interventions have a positive impact in reducing negative attitudes toward patients, diminishing in consequence treatment gap. In accordance to this theoretical framework, the principal objective of this study was to evaluate in a group of female psychology students, their attitudes toward mental illness determining their perception of danger and aggressiveness in a schizophrenic patient. We hypothesized that perception of dangerousness and aggressiveness will correlate with more negative attitudes to mental illness. Additionally, we compared attitudes to severe mental illness according to other variables related to mental health literacy such as knowledge of etiology of illness and treatment options, among female student in their first half of their career and female student in their second half. We hypothesized that advanced student will have a higher level of mental health literacy and less negative attitudes to mental illness. Method A total of 110 female psychology students from a university in Mexico City were included in the study. Group's mean age (±SD) was 21.6 (1.7) years (range 19-33 years). All subjects gave their consent to participate in a voluntary and anonymous manner. Sixty five students (59.1%) were at the initial half-stage of their career (1st to 5th semester), and forty five (40.9%) were at their last half-stage (6th to 10th semester). The study was approved by the Institutional Research and Ethical Committees (Instituto Nacional de Psiquiatría Ramón de la Fuente), and by the university's authorities. The Opinions about Mental Illness Scale (OMI), previously translated and standardized in our country (OMI-M), was used to evaluate personal attitudes toward severe mentally ill persons. OMI-M is a 34-item self-report questionnaire which evaluates attitudes utilizing a 5-points Liker scale procedure (1 = totally disagree; 5=totally agree). Evaluation includes six factors: 1. Separatism, which emphasizes the persons' perceived differences about a mental disorder and the desire of keeping a distance to be safe; 2. Stereotyping, defined as conceiving mentally ill persons in accordance to certain behavioral and intellectual patterns; 3. Restrictiveness, which includes items that uphold an uncertain notion regarding the rights of mentally ill persons; 4. Benevolence, which evaluates compassion to the mentally ill; 5. Pessimistic prediction, referring to the perception that mentally ill persons are incapable of improving on their symptoms and how society is also not optimistic in this respect; 6. Stigmatization, build upon items that perceive mental illness as a cause of shame. The Public Aggressiveness Concept Questionnaire, a self-rated instrument was also applied in the study. This questionnaire evaluates the perception of aggressiveness after reviewing a standardized clinical vignette of a patient with an active paranoid schizophrenia. The reviewer is asked to answer questions regarding the identification of aggressive conduct in the vignette, including the presence and intensity of verbal and physical violence. In another section, the way symptoms could be controlled is evaluated. Additional questions are included in the final section of the questionnaire aimed to evaluate concepts such as if the reviewer considers that the person in the vignette has a mental illness, what causes might originate this condition, and if he or she perceives the subject as socially dangerous. Data analysis was carried utilizing the SPSS, version 17.0, statistical program. Categorical variables description was done with rates and percentages; continuous variables were analyzed with means and standard deviation.

Introducción El temor y el rechazo han sido las principales actitudes negativas hacia las personas con trastornos mentales graves como la esquizofrenia. Éstas surgen de la percepción pública de que los pacientes no tienen control sobre su comportamiento y son agresivos, violentos y/o peligrosos; tienen un impacto directo en las personas que padecen esquizofrenia y sus familiares, y aun cuando podría esperarse lo contrario, diversos estudios han mostrado que los profesionales de la salud en general, y de la salud mental en lo particular, muestran actitudes negativas hacia los pacientes con esquizofrenia. Diversos estudios internacionales han demostrado que las campañas dirigidas a incrementar la alfabetización en salud mental (ASM) son efectivas para modificar las actitudes negativas hacia las personas con trastornos mentales. Sin embargo, las necesidades de ASM pueden tener variaciones locales, por lo que resulta necesario conocer las actitudes hacia la enfermedad mental y los factores asociados a las mismas en las poblaciones blanco a las que se dirigirán las campañas antiestigma en una región particular. En esta dirección, el objetivo principal del presente estudio fue comparar las actitudes de mujeres estudiantes de psicología hacia las personas con trastornos mentales graves de acuerdo a la agresividad y peligrosidad percibida de un paciente con esquizofrenia. Adicionalmente, las actitudes hacia las personas con trastornos mentales graves así como las variables relacionadas con la alfabetización en salud mental se comparan entre las mujeres que cursaban la primera mitad de la licenciatura en psicología y aquellas que cursaban la segunda mitad. Método Se incluyó un total de 110 mujeres con una edad promedio de 21.6±1.7 años, estudiantes de la licenciatura en psicología de una universidad de la zona metropolitana de la Ciudad de México que aceptaron participar en el estudio de forma voluntaria y anónima. El 59.1% (n=65) se encontraba cursando la primera mitad de la licenciatura (del 1° al 5° semestre) y el 40.9% (n=45) restante, la segunda mitad (del 6° al 10° semestre). El total de la muestra completó la Escala de Opiniones sobre la Enfermedad Mental en Población Mexicana (OMI-M) para determinar las actitudes hacia las personas con trastornos mentales graves, así como el Cuestionario de Concepto Público de Agresividad (CPA), que valora el concepto público de agresividad del paciente con esquizofrenia con base en la presentación de una viñeta clínica de un paciente con esquizofrenia paranoide. Resultados El 95.5% (n=105) de las estudiantes reconocieron la presencia de una enfermedad mental en la viñeta clínica. No obstante, tan sólo el 70.9% (n=78) consideró las intervenciones psiquiátricas como las más adecuadas para el control de los síntomas. El 59.1 % (n=65) de las estudiantes consideró que el sujeto descrito en la viñeta podría ser agresivo de alguna forma y tan sólo 12.7% (n=14) lo calificó como peligroso para la sociedad. Las estudiantes que percibieron agresivo al paciente de la viñeta mostraron mayores puntajes en las áreas de restricción, predicción pesimista y en la puntuación total del OMI-M. De forma similar, aquellas que consideraron peligroso al paciente tuvieron mayores actitudes negativas en términos de separatismo, estereotipos y puntuación total del OMI-M. No se encontraron diferencias en las variables de alfabetización en salud mental (reconocimiento de la enfermedad, causas atribuibles y tratamiento sugerido), ni en la percepción de agresión y peligrosidad, ni en cuanto a las diferentes áreas evaluadas por el OMI-M entre alumnas que cursaban la primera mitad de la licenciatura en psicología y aquellas que cursaban la segunda mitad. Discusión Un alto porcentaje de estudiantes de psicología consideró agresivo al paciente descrito en la viñeta, y tal como se esperaba, esta concepción se relacionó con mayores actitudes negativas, tales como mayor nivel de restricción y de predicción pesimista. Adicionalmente, la percepción de la persona con enfermedad mental como alguien con capacidades limitadas y comportamiento extraño parece promover la distancia social. Tanto la percepción de agresión como la de peligrosidad y las actitudes negativas asociadas en esta muestra nos hablan del poco entendimiento que pudieran tener los estudiantes de psicología en relación con las experiencias vividas por los pacientes. Aun cuando nuestros resultados no pueden ser generalizados al total de los estudiantes de psicología del país, es posible sugerir la inclusión al currículo educativo de información clara y objetiva sobre aspectos psicosociales de la enfermedad -estigma y actitudes hacia la enfermedad- y no sólo aspectos teóricos sobre la fisiopatología del trastorno y características sintomáticas del padecimiento; así como el contacto regular, tanto hospitalario como comunitario, con los pacientes.

Introduction There are growing scientific data that show the potential therapeutic benefit of treating depression with acupuncture. The most studied mechanisms of action of antidepressants, such as the monoamine oxidase inhibitors, tricyclic antidepressants or serotonine reuptake inhibitors, are their ability to enhance the synaptic availability or the binding of these monoamines to their respective receptors and their effect on adaptations within signal transduction pathways downstream from monoamine receptors. Life stressors or psycho-social events play a significant role in precipitating a first or second episode of major depression. Physiologically, stress activates the Hypothalamic-Pituitary-Adrenal (HPA) axis. Activation of the axis begins with the release of a corticotrophin-releasing factor (CRF), which stimulates the remainder of the cascade, successively prompting the release of adrenocorticotrophic hormone (ACTH) and cortisol. Multiple reports have related HPA axis hyperactivity, including CNS (i.e., corticotrophin-releasing factor), pituitary (i.e., adrenocorticotrophic hormone), and adrenal (i.e., cortisol) to major depression, and suicide behaviour. One of the resources of TCM for the treatment of depression is acupuncture, and it has been suggested as an alternative to antidepressants for its action on the brain monoaminergic systems. Up to now, there are a few examples of randomized and controlled clinical trials of the effect of acupuncture and electroacupuncture on major depression and we have obtained similar results when using acupuncture and electroacupuncture or conventional antidepressant drugs. Since the 1970's many reports have been done to explain the mechanism of action of acupuncture. Some studies performed in humans and animals studies had found an increment in the levels of 3-endorphin, ACTH and cortisol following low frequency electroacupuncture. The release of ACTH and cortisol suggests that electroacupuncture is acting on the HPA axis and through this mechanism could have a modulatory effect on the stress system and depression. The influence of acupuncture on different neurotransmitter systems like 3-endorphin itself or monoamines, like noradrenaline and serotonine, can also mediate effects of acupuncture on mood and behavior. The aim of this study was to establish the effect of a low frequency electroacupuncture point formula on the clinical improvement of depressed patients and its relation with changes on salivary cortisol. Material and methods Subjects: 42 patients, recruitment and Study Population, at a Universitary Primary Care clinic and randomly divided into control (sham acupuncture) or case group (real acupuncture). Intervention: Low frequency electroacupuncture point formula Main Outcome Measures: Clinical score in the Carroll Scale for Depression and psychiatric Symptoms Check List (SCL-90). Salivary cortisol Results The formula used in this study showed a major effect on the reduction of the depressive symptomatology of patients studied compared to the control group. Conclusions To our knowledge, this is the very first report on acupuncture treatment that evaluates depression symptoms and its evolution using the Carroll rating scale. Effect over depressive symptomatology was higher in the real acupuncture group than in the sham acupuncture group. Taking all data together, the formula used in this study showed a major effect on the reduction of the depressive symptomatology and Cortisol levels of patients studied compared to the sham control group.

Antecedentes La medicina moderna describe la depresión como una enfermedad mental, que se caracteriza por al menos dos semanas continuas de presentar alguno de estos síntomas: labilidad emocional, pérdida del interés en actividades que resultaban placenteras, sentimientos de culpa y aburrimiento, nivel de energía notablemente disminuido, cambio en el patrón de sueño y en el apetito, pérdida de la concentración, agitación psicomotora, pensamientos relacionados con la muerte, sentimiento de desesperanza, irritabilidad y decremento de la libido, afectando las diversas áreas de funcionamiento: sociales, laborales e interpersonales. Investigaciones recientes han encontrado que los trastorno afectivos muestran un beneficio terapéutico en el tratamiento con acupuntura. Se sabe que el estrés de los eventos de la vida pone a las personas en alto riesgo de presentar un cuadro depresivo. Psicológicamente el estrés activa el eje hipotalámico- adrenal-pituitario (HPA); esta activación del eje comienza con la relación del factor liberador de corticotropina, el cual estimula el resto de la cascada, promoviendo sucesivamente la producción de hormona adrenocorticotrópica. Eje hipotálamo-hipófisis-adrenal. La activación de este eje comienza con la liberación del Factor liberador de corticotropina (FLC), que estimula una cascada que sucesivamente incrementa la liberación de la hormona adrenocorticotrópica (ACTH) y el cortisol. Múltiples reportes han relacionado la hiperactividad de este eje con la depresión mayor y la conducta de suicidio. Se ha sugerido que el hipercortisolismo puede ser un factor relevante en la patogénesis de la depresión. Otros hallazgos que refuerzan la hipótesis anterior son el incremento de cortisol y los pulsos secretores de ACTH, así como los niveles elevados de CRF en el fluido corticoespinal, y un incremento de neuronas secretoras de CRF en la región límbica del cerebro con una disminución del número de receptores de CRH en la corteza frontal, y alteraciones en la prueba de supresión con dexametasona en pacientes deprimidos. Dentro de la perspectiva de la acupuntura, la depresión es tratada con el método de nutrir al corazón y calmar la mente, regulando la energía y la sangre. Por lo anterior, se sugiere la acupuntura como una alternativa para la sintomatología de la depresión, ya que por su acción en el sistema monoaminérgico en el cerebro actúa como antidepresivo. Algunos estudios han reportado el efecto de la acupuntura y la electroacupuntura en la depresión mayor, mostrando resultados similares al uso de las drogas antidepresivas. También la acupuntura y la electroacupuntura han demostrado en algunos estudios, tanto en humanos como en animales, el incremento de los niveles de p-endorfinas, ACTH y cortisol. La relación del ACTH y el cortisol sugiere que la electroacupuntura activa el eje HPA y a través de este mecanismo se puede modular el efecto en el sistema de la depresión y el estrés, así como la influencia de la acupuntura en los diferentes neurotransmi-sores del sistema, como las p-endorfinas, monoaminas, noradrenalina y serotonina. Objetivo Establecer el efecto de la baja frecuencia de electroacupuntura en los puntos clínicos adecuados para manejar la depresión en relación con el cortisol en la saliva. Material y métodos Cuarenta y dos pacientes de la población general, divididos en grupo control y grupo experimental, siguiendo un diseño doble ciego, haciendo una intervención de baja frecuencia de electroacupuntura, en puntos adecuados y en puntos placebo, midiendo el cortisol en saliva y utilizando la escala de Carroll para medir sintomatología depresiva y la escala de síntomas psiquiátricos (SCL - 90). Resultados La fórmula utilizada en el estudio mostró un mayor efecto en la reducción de la sintomatología depresiva en los pacientes del grupo experimental que en los pacientes pertenecientes al grupo control. Estos resultados fueron observados hasta la sexta semana de tratamiento. La fórmula utilizada en este estudio mostró una disminución en los niveles de cortisol en los pacientes del grupo control. Conclusiones Desde nuestro punto de vista, éste es el primer reporte del tratamiento acupuntural que evalúa la sintomatología depresiva usando la escala de Carrol. El efecto sobre la sintomatología depresiva fué mayor en el grupo de acupuntura real que en el de acupuntura ficticia. Consideramos este efecto una respuesta parcial porque no hubo al menos una reducción de 50% de la sintomatología depresiva, la que se pudiera convertir en una respuesta completa si los pacientes fueran tratados por mayor tiempo o con otros esquemas acupunturales de tratamiento. Tomando en conjunto todos los datos, la formula usada en este estudio mostró un mayor efecto en la reducción de la sintomatología depresiva y en los niveles de cortisol en el grupo de los pacientes estudiados comparado con el grupo de los pacientes control.

Summary Bipolar spectrum disorder which includes bipolar I, bipolar II, ciclothymia and bipolar disorder, not otherwise specified often goes unidentyfied, underdiagnosed, or confounded with major depressive disorder. There are several considerations that try to explain this frequent omission. One crucial aspect is that, the first mood episode at onset is often a depressive one, and some bipolar patients present multiple depressive episodes prior to their first episode of mania. Additionally, long-term evaluation of patients with bipolar I or II disorders, reveal that depressive symptoms occur more common than manic or hypomanic symptoms. Another plausible explanation is that bipolar patients frequently underreport symptoms of mania. Thus it is not surprising to find that in many patients, may elapse about 10 years from the first time for they seek treatment until a clinician finally makes the correct diagnosis. As a consequence, such patients may suffer poorer outcomes, subsyndromal symptoms and a course of illness marked by more sever symptoms, chronic mood episodes, increased recurrence and more impaired psychosocial functioning. The correct diagnosis of bipolar disorder becomes an important and crucial issue, if it is considered that there is a current trend to understand better this affective illness as a spectral disorder. This concept helps to identify different subtle subtypes of bipolarity which often are unrecognized, by means of the actual diagnostic criteria. This diagnostic reformulation is based on the phenomenological manifestations of the entities, as well as in other specific clinical aspects, such as comorbidity, predominant episodes, genetic information and treatment response to among others. Thus, correct recognition of bipolar disorder will bring an important benefit to patients and may reduce erratic treatments and improve outcome. Several epidemiological studies report that the global prevalence of bipolar I disorder is around 1%, in the general population, but when considering all subtypes included in the bipolar spectrum, this lifetime prevalence increases up to 5%. As a consequence of an incorrect diagnosis, patients are often undertreated or receive an erroneous pharmacological treatment, mainly with antidepressants, which complicate outcome by promoting manic or hypomanic reactions and may have devastating consequences in the further clinical intents to stabilize the disorder. In order to increase the recognition of an illness, the correct utilization of a clinical screening procedure is mandatory. Several screening instruments exist for a variety of psychiatric disorders. However, only until recently, some of them have been developed specifically to identify bipolar disorders. The Mood Disorder Questionnaire, was the first screening instrument specifically developed to detect bipolar cases in clinical settings. It is a self-report, single-page, paper and pencil inventory than can be quickly and easily scored by a physician, a nurse or by trained medical staff assistance. It is composed of 13 questions which are answered with a positive or negative fashion, elaborated from the bipolar diagnostic criteria and clinical experience and inquires about possible manic symptoms. In the original report of its development and validation, it was concluded that it is a useful screening instrument for bipolar spectrum disorders, with a good sensitivity (0.73) and a very good specificity (0.90). Method: The questionnaire has been translated to other languages and has been used in non-clinical settings, with very good standards of performance. Since there is not a Spanish version of it, we decided to translate this instrument and to design a trial for the following purposes: 1) to obtain a validated and understandable Spanish version of the questionnaire. 2) To determine its sensibility and specificity in a sample of patients with affective disorders. 3) To identify its optimal cutoff score for screening purposes. The first step in our study consisted in the development of a translated version of the instrument. For that purpose a translation- retranslation procedure was utilized, in which four clinical psychiatrists with experience in treating bipolar patients made each one a separate translation. Then, all the versions were discussed until a consensus was reached in a final version. This version was retranslated to English and, after making some adjustments, the final version in Spanish was concluded. The study aimed to determine the clinimetric parameters of the Mood Disorder Questionnaire in its Spanish version, was conducted at the outpatient affective disorders clinic in the National Institute of Psychiatry Ramón de la Fuente, in México City. Patients with an age of 18 years and over who looked for psychiatric consultation, due to the presence of affective disorder were invited to participate. After explaining the procedure and the purposes of the study, all those who accepted to participate, signed 51 an informed consent document. This study was approved by the Ethical Committee of our institution. All patients completed the Mood Disorder Questionnaire. Two experienced clinical psychiatrists, blind to the questionnaire results, applied the Structural Clinical Interview for DSM-IV (SCID) to obtain the specific affective diagnosis in all the patients. Clinical and demographic data, as well as results from the clinical interview and questionnaire’s scores, were obtained and then analyzed. Sensitivity and specificity for each Mood Disorder Questionnaire score, were plotted by using results from the SCID interview as a standard. Sensitivity (percent of criterion standard diagnosis correctly diagnosed by the questionnaire) and specificity (percent of criterion standard noncases correctly identified as noncases by the questionnaire) were obtained by using different symptoms, threshold that ranged from 5 to 10 points in order to determine the optimal screen threshold. Results: A total of 100 patients were included in the study. Mean age for the complete group was 35.3 years and 64% were female. According to the SCID results, 49 patients had a diagnosis within the bipolar spectrum disorder and 51 had a unipolar affective diagnosis. Each group included patients with both first and recurrent episodes, and with and without comorbidities. The questionnaire was completed by the total sample of patients covering the total range of answer’s possibilities, from non-positive responses (1% of the sample) to 13 positive responses (15% of the sample). Mean score (± SD) was 8.06 (3.5) with a significant difference between patients in the bipolar group (10.3 ± 2.7) and patients in the unipolar group (5.8 ± 2.7); t = -8.2, 98 gl, p<0.001. Using different cutoff scores sensitivity and specificity were calculated, observing that with a 10 point cutoff score, equilibrated sensitivity (0.71) and specificity (0.92) levels were obtained. Conclusions: The study was aimed to obtain an adequate translated version into Spanish of the Mood Disorder Questionnaire, and to determine its sensitivity and specificity, according to an optimal cutoff score, for correctly detecting bipolarity from a sample of affective disorder patients. With a reliable procedure of translation process, we obtained a satisfactory, understandable and easy to use version for patients. Similar to other reports, a structured clinical interview was utilized to obtain the patients diagnoses. After evaluating with different cutoff scores, we found that a score of 10, gives an adequate distribution for levels of sensitivity and specificity. However, lower scores (between 7 and 9), also give adequate levels of sensitivity and specificity. It is important to consider, that our study was done in a very specific sample of patients who had only affective disorders. With these type patients it is necessary to raise the bar sufficiently to obtain adequate results. In other studies that included non-affective patients the questionnaire worked well with lower cutoff points. The operating characteristics of the Mood Disorder Questionnaire in its Spanish version are sufficiently good to consider its application as a reliable screening instrument for detecting bipolar spectrum disorders at least, in an affective disorders clinical setting. Further studies are needed to evaluate whether the instrument would be useful in other psychiatric settings as well as in community or primary care samples, and also to determine the best cutoff point depending in the characteristics of the population in which it is being used.

resumen está disponible en el texto completo